According to the publication of the magazine very interesting, after ten years of research, scientists at the Institute Vaccine and Gene Therapy at the University of Oregon (USA) have developed an experimental vaccine that has helped Rhesus macaques with a form of AIDS virus-Virus Inmodeficiencia of Simla or SIV-infection control for over a year.
According to the researchers, the new vaccine stimulates the immune system to rapidly attack the virus when it first enters the body, when it is most vulnerable.
So far, the vast majority of vaccinated monkeys have kept the virus in check for more than a year, gradually losing all signals were being infected. By contrast, the monkeys in the unvaccinated group have since developed the form of AIDS that affects monkeys.
"We think (the vaccine) has the ability to keep the virus under control or completely eliminate the virus," says Louis Picker, author of the study published in the journal Nature, which believes it will be possible to have a vaccine ready for testing in people within three years.
To introduce the vaccine into the body of the primates, Picker and colleagues used a relatively harmless virus called cytomegalovirus (CMV) as a transport system.
He was elected because scientists believe that most people are already infected with this virus, which remains in the body for life but causes few or no symptoms in most infected.
0 comments:
Post a Comment